Evidence map›Paper›PMID 33283221›Full record

ArticleArchives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists2021

Metabolic Syndrome and Cognitive Function in Midlife.

Janelle T Foret, Stephanie Oleson, Brennan Hickson, Stephanie Valek, Hirofumi Tanaka, Andreana P Haley

Open access · bronzeAbstract read
In one paragraph

Article in Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Metabolic syndrome and cognitive deficits in the Greek cohort of Epirus Health Study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Metabolic Syndrome and Cognitive Function.Current cardiology reports · 2021
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Janelle T ForetDepartment of Psychology, The University of Texas at Austin, Austin, TX, USA.
Stephanie OlesonDepartment of Psychiatry and Biobehavioral Sciences, Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, USA.
Brennan HicksonDepartment of Kinesiology and Health Education, The University of Texas at Austin, Austin, TX, USA.
Stephanie ValekMcGovern School of Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.
Hirofumi TanakaDepartment of Kinesiology and Health Education, The University of Texas at Austin, Austin, TX, USA.
Andreana P HaleyDepartment of Psychology, The University of Texas at Austin, Austin, TX, USA.
The University of Texas at Austin · US

Funding

Cognitive Enhancement Through Transcranial Laser TherapyR21AG050898 · NIA · UNIVERSITY OF TEXAS AT AUSTIN · PI HALEY, ANDREANA PETROVA · 2016 to 2017
$426k
NIA NIH HHS R21 AG050898NIH HHS R01NS75565
6 · The paper itself

Abstract

objectiveMetabolic syndrome (MetS) is a cluster of cardiovascular risk factors associated with cognitive decline. We investigated the relationship between MetS and cognition in middle-aged adults. We hypothesized that higher numbers of MetS components will relate to poorer performance on executive function (EF) tasks as frontal lobe regions critical to EF are particularly vulnerable to cardiovascular disease.

methods197 adults (ages 40-60) participated. MetS was evaluated using established criteria. Composite scores for cognitive domains were computed as follows: Global cognitive function (subtests from the Wechsler Abbreviated Scale of Intelligence, 2nd Edition), EF (Stroop Color Word, Digit Span Backward, and Trails A and B), and memory (California Verbal Learning Test, 2 Edition).

resultsHigher number of MetS components was related to weaker EF-F(4, 191) = 3.94, p = .004, MetS components ß = -.14, p = .044. A similar relationship was detected for tests of memory-F(4, 192) = 7.86, p < .001, MetS components ß = -.15, p = .032. Diagnosis of MetS was not significantly associated with EF domain score (ß = -.05, p = .506) but was significantly associated with memory scores-F(4, 189) = 8.81, p < .001, MetS diagnosis ß = -.19, p = .006.

conclusionsOur findings support prior research linking MetS components at midlife to executive dysfunction and demonstrate that MetS, and its components are also associated with poorer memory function. This suggests that cognitive vulnerability can be detected at midlife. Interventions for MetS at midlife could alter cognitive outcomes.

Indexed as

Cognitive DysfunctionMetabolic SyndromeAdultCognitionExecutive FunctionHumansMiddle AgedNeuropsychological TestsAgingBrainCognitive impairmentExecutive functionMetabolic syndromeNeuropsychological assessment

Identifiers

PMID33283221
PMCPMC8406647
OpenAlexW3113337118

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.